Apoptosis of lung adenocarcinoma cells induced by amentoflavone and its mechanism
沈飞,黄斌,沈凯,吴松,虞桂平
DOI: https://doi.org/10.3760/cma.j.cn421213-20190929-01396
2020-01-01
Abstract:Objective:To investigate the effect of amentoflavone (AF) on lung adenocarcinoma cells and its action mechanism.Methods:Human lung adenocarcinoma H1299 cells were selected, and control group, AF 5 μmol/L group and AF 10 μmol/L group were set up. The effects of AF on viability of H1299 cells were examined by colony formation assay, Hoechst staining, flow cytometry (FCM) and Western blotting. The 8-week BALB/c male mice were subcutaneously injected with H1299, and control group, AF 20 mg/(kg·d) group and AF 40 mg/(kg·d) group were set up. The sizes and weights of the tumor tissues were measured. The effects of AF were observed by terminal-deoxynucleotidyl transferase mediated nick end labeling (TUNEL). Isotopic quantitative analysis was used in the discovery of differential protein phosphatase 2A inhibitor (CIP2A). The expression of protein CIP2A was detected by Western blotting. By building CIP2A low expression cells and CIP2A over-expression cells, AF 10 μmol/L group, CIP2A over-expression+ AF 10 μmol/L group and CIP2A low-expression+ AF 10 μmol/L group were set up. Cell proliferation and apoptosis were observed by Hoechst and FCM. The Graph Pad Prism was used to analyze the mean values of the two samples.Results:In the cell experiment, the proliferation percentage of lung adenocarcinoma cells in the AF 5 μmol/L group [(75.12±3.11)%,
t=9.638,
P<0.01] and the AF 10 μmol/L group [(58.01±4.02)%,
t=11.382,
P<0.01] was significantly lower than that in the control group [(100.02±8.11)%]. The percentage of cells in G
0/G
1 phase was significantly higher in the AF 5 μmol/L group [(55.23±2.21)%,
t=6.928,
P<0.01] and the 10 μmol/L group [(65.33±3.23)%,
t=10.132,
P<0.01] than in the control group [(47.12±3.32)%]. The apoptosis rate of lung adenocarcinoma cells in the AF 5 μmol/L group [(12.38±0.51)%,
t=26.583,
P<0.01] and the AF 10 μmol/L group [(21.88±0.95)%,
t=43.709,
P<0.01] was significantly lower than that in the control group [(2.29±0.13)%]. The expression of CIP2A protein in the AF 5 μmol/L group (0.72±0.02,
t=9.782,
P<0.01) and the AF 10 μmol/L group (0.49±0.03,
t=19.816,
P<0.01) was significantly lower than that in the control group (1.00±0.02). In the animal experiments, the tumor volume in the experimental group was significantly reduced as compared with that in the control group (
P<0.05). The tumor weight in the AF 20 mg/(kg·d) group [(438.33±30.40) mg,
t=19.036,
P<0.01] and the AF 40 mg/(kg·d) group [(255.83±24.58) mg,
t=60.782,
P<0.01] was significantly reduced as compared with that in the control group [(810.83±30.40) mg]. CIP2A protein expression in tumor tissues was significantly lower in the AF 20 mg/(kg·d) group (0.60±0.03,
t=31.529,
P<0.01) and the AF 40 mg/(kg·d) group (0.43±0.03,
t=40.613,
P<0.01) than that in the control group (1.00±0.01). TUNEL showed that AF significantly increased the apoptosis of tumor cells. The anti-proliferative activity of the CIP2A low-expression+ AF 10 μmol/L group (0.49±0.03,
t=8.012,
P<0.01) was significantly stronger than that in the AF 10 μmol/L group (0.60±0.03). The pro-apoptotic activity of the CIP2A low-expression + AF 10 μmol/L group (28.06±0.89,
t=17.663,
P<0.01) was significantly stronger than that in the AF 10 μmol/L group (22.02±0.73). The anti-proliferative activity of the CIP2A overexpression + AF 10 μmol/L group (0.80±0.05,
t=10.484,
P<0.01) was significantly weaker than that in the AF 10 μmol/L group (0.58±0.04). The pro-apoptotic activity in the CIP2A overexpression + AF 10 μmol/L group (8.13±0.68,
t=37.165,
P<0.01) was significantly weaker than that in the AF 10 μmol/L group (22.02±0.73).
Conclusion:AF could promote apoptosis of lung adenocarcinoma cells, and AF showed anticancer activity in lung adenocarcinoma cells through target gene CIP2A.